Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
CAV1 expression
Cancer:
Non Small Cell Lung Cancer
Drug:
amlodipine/atorvastatin
(
HMG-CoA reductase inhibitor
,
Ca2+ channel antagonist
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Source:
Theranostics
Title:
CAV1 - GLUT3 signaling is important for cellular energy and can be targeted by Atorvastatin in Non-Small Cell Lung Cancer
Excerpt:
Atorvastatin suppresses growth by inhibiting Cav1 expression in tumors in cell culture system and in in vivo models.
Secondary therapy:
paclitaxel + carboplatin
DOI:
10.7150/thno.35805
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login